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Oxidative modification of low-density lipoprotein (EDL) enhances its uptake by macrophaps in tissue culture and in vivo may underly the forma- 
tion of arterial fatty streaks. the progenitors of atheroma. We investigated the possible protection which high-density lipoprotein (HDL) affords 
against LDL oxidation. The formation of lipoperoxides and thiobarbituric acid reactive substances when LDL was incubated with copper ions 
was significantly decreased by HDL. The enzyme, paraoxonase (E.C. 3.1.&l), purified from human HDL, had a similar effect and thus may be 
the component of HDL responsible for decreasing the accumulation of lipid peroxidation products. 
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1. INTRODUCTION 
Oxidation of low-density lipoprotein (LDL) by redox 
metaIs, macrophage, smooth muscle or endotheIiaI cells 
in tissue culture modifies its structure so that it binds to 
the acetyl low-density lipoprotein receptor of 
monocyte-derived macrophapes [ l&2]. Its subsequent 
avid uptake by these cells in vitro leads to the formation 
of foam cells. These resemble the main cell type of the 
arterial fatty streak, the progenitor of atheroma. It has 
been suggested that similar events may occur in vivo 
leading to atherogenesis. Epidemiological evidence has 
revealed that whereas the LDL concentration in the 
plasma related directly to the risk of developing cor- 
onary heart c!isease, high-density lipoprotein (HDL) is 
inversely related to risk [3]. However, the mechanism 
for the apparently protective ffect of HDL remains a 
mystery (41. It is known that the oxidative damage to 
low-density lipoproteins proceeds via the formation of 
lipoperoxides of phospholipids containing unsaturated 
fatty acids. These break down to release reactive 
aldehydes and thence through a phospholipase A2 reac- 
tion to lysophospholipids [5]. Here, we report the 
prevention of lipoperoxide generation during the 
Cut+-induced oxidation of low-density lipoprotein, by 
high-density lipoproteins and one of their component 
enzymes, paraoxonase (EC 3.1,8,1) [6]. 
2. MATERIALS AND METHODS 
2. I. Prepararion of lipoproteins 
Low-density lipoproteins (LDL), high-density lipoprotein (HDL) 
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and its subfractions HDLz and HDLs were prepared by sequential 
ultracentrifugation [7] from the serum of 7 normolipidaemic 
volunteers, one patient with heterozygous familial hyper- 
cholesterolaemia (FH) and one subject with homozygous FH. After 
exhaustive dialysis against phosphate-buffered saline (PBS) (0.04 M, 
pI-I 7.3) lipoproteins were stored at 4’C under nitrogen until used. 
2.2. Purification of paraoxonase 
Paraoxonase was purified from the serum of a female donor as 
described [S] which results in a single band on SDS-PAGE. The 
resulting preparation was 900-fold purified with respect to serum. 
2.3. Oxidation of LDL by Cd+ 
LDL was oxidised as described [9]. Either 0.1 mg of LDL protein 
(in experiments to determine the amount of thiobarbituric acid reac- 
tive substances (TBARS)), or I .5 mg of LDL protein (for lipoperox- 
ide determination) was incubated in EDTA-free PBS with 5 pM 
CuSOn in the presence or absence of HDL, HDL2, HDLJ, paraox- 
onase or Tris buffer in a total volume of 1 .O ml. Blanks consisted of 
PBS plus CuSO4. Control incubations were performed omitting 
CuSO4. Oxidation was terminated by the addition of 24 yM EDTA 
and 20 /IM butylated hydroxytolucne. Incubation periods varied from 
0 to 24 h. 
2.4. Analytical procedures 
Lipid peroxidation in the incubations was estimated by two 
methods, Firstly, as the fluorescent reaction with thiobarbituric acid 
(TBARS) using tetramethoxy-propane as a standard [IO] and sccond- 
ly as the reaction with CHOD-iodide to determine lipoperoxides [ll]. 
3. RESULTS AND DISCUSSION 
HDL protected against lipoperoxide formation 
during Cu2* oxidation of LDL (Fig. I), but did not in- 
fluence the concentration of reactive aldehydes 
(TBARS) (Table I). HDL was itself resistant o oxida- 
tion compared to LDL. Both HDL2 and HDLJ gave 
protection against lipoperoxide formation and a slight, 
but non-significant decrease in detectable aldehydes 
(Table I), although the latter effect varied widely be= 
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Fig. 1. The effect of HDL on CL?+ -catalysed LDL oxidation. 1.5 mg 
of LDL and/or HDL protein was incubated at 37°C in the presence 
or absence of 5 FM Cu*+ in a total volume of I ml (made up with 
PBS) for various times before assay for lipoperoxides as described 
[Ill. Blanks consisted of PBS -t CL?+ only. (W) LDL with Cu2+, 
(A---A) LDL without Cuzc, (C--o) HDL with Cu’+, (O-*-O) HDL 
without CL?, (O--U) LDL plus HDL with Cu”, (m---e) LDL plus 
HDL without Cuzs. The figure shown represents a typical 
experiment. Points are the mean of duplicate determinations. 
tween individual preparations of LDL. This difference 
between protection against lipopeeoxide and aldehyde 
formation may have been due to the hydrophobic en- 
virsnment of the lipoproteins. The TBARS formed dur- 
ing LDL oxidation are partially water-soluble. They 
may therefore have escaped into the aqueous environ- 
ment and have bren unavailable to HDL or its subfrac- 
tions whereas the lipoperoxides remained in the lipid 
environment where they could interact with HDL. Since 
the level of TSARS was less than that of the lipoperox- 
ides, the lack of effect of HDL on TBARS was not in- 
dicative of its potential to protect against oxidative 
modification of LDL. Indeed it has previously been 
reported tha,t HDL prevents the changes in LDL elec- 
trophoretic mobility caused by oxidation [I%] and that 
HDL will prevent LDL subjected to oxidising condi- 
tions from being taken up by cultured macrophages 
i131. 
In our experiments the abolition of lipeperoxide 
generation by HDL was not confined to any single sub- 
fraction (Table I). Overall, as in the case of whole 
HDL, neither I-IDLz or HDLr significantly altered the 
production of TSARS. However, there was a greater 
tendency for the subfractions to do so which was more 
obvious with some LDL preparations. Although an 
unexplained similar phenomenon has previously been 
observed when HDL was immunologically fractionated 
[12]. Paraoxonase prevented both TBARS and 
lipoperoxide formation (Table I), only 1 ,~g of paraox- 
onase protein was required to produce the observed ef- 
fect. The activity of the paraoxonase preparation was 
4 126 nmol paraoxon hydrolysed/min/mg protein com- 
pared to a serum activity for healthy individuals (n = 
Table I 
The effect of HDL2, HDL3 and paraoxonase on Cu’+-catalysed LDL oxidation 
Incubation 
mixture 
Lipoproteins 
nmol/mg LDL % of LDL 
protein/h response 
- 
TBARS 
nmol malondialdehyde crlo of LDL 
equivalents/mg LDL response 
protein/h 
LDL 19.3 f 1.7 100 0.39 * O.OG 100 
LDL + Tris buffer 19.5 f 2.1 101 0.363 s 0.063 93.1 
LDL + HDt 2.89 f 0.15 14.9** 0.24 & 0.031 62.5 
LDL c HDL;! 0.46 f 0.06 2.4*+ 0.25 f 0.026 64, I 
LDL + HDLs 0.11 ztz 0.02 0.6” 0.227 f 0.027 58.2 
LDL + paraoxonase 15.3 f 2.3 79.3**** 0.08 * 0.017 20.5+** 
For lipoperoxide determination: 1 .S mg of LDL protein was incubated (i) alone, (ii) plus Tris buffer’, 
(iii) plus I.5 mg HDL, (iv) plus I .5 mg HDLz protein, (v) plus 1.5 mg HDLa protein, (vi) plus I ,~g 
paraoxonase. Blanks consisted of PUS + Ct?* only. Incubation was at 37OC in the presence of 5 ,uM 
Cu’*. Lipoperoxides were mcarurcd as described (11). For TBARS determination: SOrg of LDL 
protein wns incubated (i) alone, (ii) plus Tris buffer, (iii) plus SO Fg HDL, (iv) plus 5Opg HDL1, (v) 
plus 50 /rg HDLa, (vi)~plus 1 bry paraoxonase, t3lanks consisted of PBS + Cu** only. Incubation was 
at 37°C in tlrc presence of 5 IAM Cu ‘*. TRARS were measured as described [IO]. Figures arc mean k 
SE of the mean of9 determinations. l Tris burrer = 0,025 M Tris/HCI, pH 8.0, containing 0.005 M 
CaCIz, S crM EDTA, 20% (v/v) glycerol and 0.2% (v/v) Emulgen 911 and is the buffer in which 
prraoxonaac is purified. +* Statlatically slgtilficatit from LBL. response P c 0.001. *+* Statistically 
significant from LBL response P c O&OS. l *** Statistically significant from LDL response P r: 0,Ol 
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79) of 1 I9 nmol ( + 117, - 59) paraoxon hydro- 
Iysed/min/rnl serum<geometric mean f 1 SD, - i SD) 
[9]. In the circulation more than 85% of paraoxonase 
activity is located on HDL and the rest is not associated 
with lipoprotein /6]. The spesific activity of paraox- 
onase on HDL is approximately 50 nmol/min/mg 
HDL protein. Our experiments tested the effect of 
1.5 mg of HDL protein which thus contained 
75 nmol/min of paraoxonase activity. The greater ef- 
fect of HDL in preventing lipoperoxidation is probably 
therefore explicable because it was compared with an 
activity of 4 nmolJmin in the experiments with purified 
enzyme. 
Paraoxonase isknown to hydrolyse organophosphate 
insecticides and nerve gasses [14]. Nowever, its 
physiological role is unknown. It is possibIe that a 
biological action of paraoxonase is to hydrolyse lipid 
peroxides formed during the oxidation to harmless car- 
boxylic acids. This possibility is being investigated in 
detail in our laboratory. This action may form the basis 
by which I-IDL protects against he development of cor- 
onary artery disease by preventing lipid peroxidation in 
LDL and ultimately, foam ccl1 formation. It has not 
escaped our attention that HDL, which is present in 
tissue fluids at concentrations which even in the human 
are IO-fold greater than those of LDL [4], may have a 
more general role in protecting against oxidative 
damage in biologica systems. 
Other HDL enzymes such as lecithin cholesterol 
acyltransferase (LCAT) (EC2.3.1.43) and protease (EC 
3.4.4.7) could also be involved in the protective func- 
tion of HDL. However, the paraoxonase preparation 
used in these experiments was not contaminated with 
either LCAT or protease activity. Final proof of the 
role of paraoxonase could be obtained by the use of 
specific inhibitors of the enzyme. However, its two 
competitive inhibitors, which are highly toxic [15], are 
currently unavailable. 
In the context of the potential of paraoxonase to pro- 
tect against oxidative modification of LDL, it is in- 
teresting to note that serum paraoxonase activity is 
decreased in both diabetes and familial hyper- 
cholesterolaemia 1161, two diseases in which there is a 
greatly increased risk-of coronary heart disease and its 
serum activity is also decreased inmyocardial infarction 
survivors /17]. The diversity of diseases, in the aetiology 
of which free radicals have been imputed, emphasises 
the cogent need for further examination of the 
biological role of I-ID% and paraoxonase. 
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